Add Yahoo as a preferred source to see more of our stories on Google. Compounded GLP-1 drugs aren't FDA-approved and may carry unknown safety risks. Experts warn of inconsistent quality, dosing and ...
On April 30, 2026, the U.S. Food and Drug Administration announced that it is proposing to exclude semaglutide, tirzepatide, and liraglutide from ...
WEST LAFAYETTE, Ind., and INDIANAPOLIS – A Purdue-related startup is developing the first USP 797 certified, virtual pharmacy cleanroom laboratory for students and other industry professionals to gain ...
Over the past few weeks, the FDA has devoted lots of attention to compounding pharmacies, issuing two new guidance documents pertaining to their fundamental scope, a guidance document regarding ...
When you have to go on a medication, your doctor will probably prescribe a premade one that's FDA-approved. But sometimes, they may want you to go on a compounded medicine that's specifically made for ...
In 2017, the FDA approved semaglutide, an injectable GLP-1 agonist medication sold under the name Ozempic, for the management of type 2 diabetes. Later, the pharmaceutical company that makes Ozempic ...
Before you fill that prescription. Reviewed by Dietitian Maria Laura Haddad-Garcia Compounded GLP-1 drugs aren't FDA-approved and may carry unknown safety risks. Experts warn of inconsistent quality, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results